593
Participants
Start Date
June 5, 2018
Primary Completion Date
January 18, 2021
Study Completion Date
January 18, 2021
MEDI6012
MEDI6012
Placebo
Placebo
Research Site, Budapest
Research Site, Budapest
Research Site, Prague
Research Site, Prague
Research Site, Madrid
Research Site, Madrid
Research Site, Pontevedra
Research Site, Ústí nad Labem
Research Site, Liberec
Research Site, Pardubice
Research Site, Brno
Research Site, Jerusalem
Research Site, Saint Petersburg
Research Site, Saint Petersburg
Research Site, Kazan'
Research Site, Haifa
Research Site, Petah Tikva
Research Site, Ramat Gan
Research Site, Tel Aviv
Research Site, Beersheba
Research Site, Jerusalem
Research Site, Belo Horizonte
Research Site, Campinas
Research Site, Porto Alegre
Research Site, Porto Alegre
Research Site, Hradec Králové
Research Site, Alkmaar
Research Site, Nijmegen
Research Site, Nijmegen
Research Site, Bydgoszcz
Research Site, Lodz
Research Site, Lodz
Research Site, Banská Bystrica
Research Site, Nitra
Research Site, Dundee
Research Site, Leeds
Research Site, Stevenage
Lead Sponsor
The TIMI Study Group
OTHER
MedImmune LLC
INDUSTRY